Pregled bibliografske jedinice broj: 736422
Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population
Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population // Endocrine research, 39 (2014), 4; 164-167 doi:10.3109/07435800.2013.875038 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 736422 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population
Autori
Suver Stević, Mirjana ; Štefanić, Mario ; Tokić, Stana ; Glavaš-Obrovac, Ljubica ; Mihaljević, Silvio ; Karner, Ivan
Izvornik
Endocrine research (0743-5800) 39
(2014), 4;
164-167
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
autoimmune; association studies; genetic; interleukin-23 receptor; polymorphism; single nucleotide; STAT3 transcription factor; thyroiditis
Sažetak
Interleukin-23 receptor (IL-23R) and signal transducer and activator of transcription 3 (STAT3) polymorphisms are common risk factors for a number of T helper (Th) 17-mediated autoimmune diseases. However, the importance of genetic variations in Th17 pathways to thyroid autoimmunity, and particularly Hashimoto's thyroiditis (HT), is not fully understood. In this study, we genotyped three single nucleotide polymorphisms (SNPs) within the IL-23R (rs11209026/p. Arg381Gln, rs7530511) and STAT3 (rs744166) genes in 217 Croatian patients with HT and 161 healthy controls using fluorescence resonance energy transfer technology and melting curve analysis of polymerase chain reaction products. None of the tested SNPs or IL-23R haplotypes was associated with HT susceptibility or disease severity. These results suggest that the studied IL-23R/STAT3 polymorphisms affecting Th17 signaling efficiency are not major determinants of HT risk in the Croatian population. Further work is necessary to determine if these loci contribute modestly or conditionally to the risk of HT.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
219-0982914-2176 - Mehanizam bioloških učinaka novih malih molekula na stanice tumora čovjeka (Glavaš Obrovac, Ljubica, MZOS ) ( CroRIS)
219-2190372-2068 - Polimorfizmi u genu za vitamin D receptor u psorijazi i atopijskom dermatitisu (Štefanić, Mario, MZOS ) ( CroRIS)
219-2190372-3119 - Genski polimorfizmi detoksikacijskih molekula u upalnim bolestima crijeva (Mihaljević, Silvio, MZOS ) ( CroRIS)
Ustanove:
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek
Profili:
Mirjana Suver Stević
(autor)
Mario Štefanić
(autor)
Ivan Karner
(autor)
Ljubica Glavaš Obrovac
(autor)
Stana Tokić
(autor)
Silvio Mihaljević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE